| Name | Title | Contact Details |
|---|---|---|
John Northcott |
Chief Commercial Officer | Profile |
Andrew Sargent |
Senior Director, IT R&D and Clinical Systems | Profile |
Jing Tao |
Director, Formulation R&D | Profile |
Roy Haskell |
Executive Director, Formulation R&D | Profile |
John Houston |
President of R&D | Profile |
Kyn Therapeutics is building a new generation of immuno-oncology therapies targeting powerful immunosuppressive metabolic networks. We envision a future where immunotherapies are the foundation of every cancer patient`s treatment, delivering rapid and durable responses. The Kyn team is composed of drug hunters, translational researchers and entrepreneurs drawn from many of the largest innovators in biotechnology supported by world-class advisors, and is backed by a seasoned board of directors anchored by OrbiMed Healthcare Fund Management and Atlas Venture. Kyn Therapeutics is headquartered in the biotech hub of Cambridge, Massachusetts.
DMS Provides Mobile, Interim, and Fixed-Site Diagnostic Imaging Services and Medical Equipment Sales, Service, Parts, Rentals.
California Life Sciences Association (CLSA) advances Californias world-leading life sciences innovation ecosystem
BioStudio Visual Communications is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
arizonia infectious disease society is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.